AU2014212268B2 - Respiratory Syncytial Virus F protein epitopes - Google Patents
Respiratory Syncytial Virus F protein epitopes Download PDFInfo
- Publication number
- AU2014212268B2 AU2014212268B2 AU2014212268A AU2014212268A AU2014212268B2 AU 2014212268 B2 AU2014212268 B2 AU 2014212268B2 AU 2014212268 A AU2014212268 A AU 2014212268A AU 2014212268 A AU2014212268 A AU 2014212268A AU 2014212268 B2 AU2014212268 B2 AU 2014212268B2
- Authority
- AU
- Australia
- Prior art keywords
- ser
- leu
- lie
- asn
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
- C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361759664P | 2013-02-01 | 2013-02-01 | |
| US61/759,664 | 2013-02-01 | ||
| US201361783380P | 2013-03-14 | 2013-03-14 | |
| US61/783,380 | 2013-03-14 | ||
| PCT/US2014/014054 WO2014121021A1 (en) | 2013-02-01 | 2014-01-31 | Respiratory syncytial virus f protein epitopes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2014212268A1 AU2014212268A1 (en) | 2015-08-20 |
| AU2014212268B2 true AU2014212268B2 (en) | 2018-07-19 |
Family
ID=51262966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2014212268A Active AU2014212268B2 (en) | 2013-02-01 | 2014-01-31 | Respiratory Syncytial Virus F protein epitopes |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10016496B2 (enExample) |
| EP (1) | EP2950886B1 (enExample) |
| JP (1) | JP6450688B2 (enExample) |
| CN (1) | CN105073196B (enExample) |
| AU (1) | AU2014212268B2 (enExample) |
| CA (1) | CA2900110A1 (enExample) |
| CY (1) | CY1122937T1 (enExample) |
| DK (1) | DK2950886T3 (enExample) |
| ES (1) | ES2778899T3 (enExample) |
| HR (1) | HRP20200404T1 (enExample) |
| LT (1) | LT2950886T (enExample) |
| PL (1) | PL2950886T3 (enExample) |
| PT (1) | PT2950886T (enExample) |
| RS (1) | RS60056B1 (enExample) |
| SI (1) | SI2950886T1 (enExample) |
| SM (1) | SMT202000145T1 (enExample) |
| WO (1) | WO2014121021A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| TWI659968B (zh) | 2013-03-14 | 2019-05-21 | 再生元醫藥公司 | 針對呼吸道融合病毒ｆ蛋白質的人類抗體及其使用方法 |
| RS60387B1 (sr) | 2014-01-15 | 2020-07-31 | Medimmune Llc | Rsv-specifična antitela i njihovi funkcionalni delovi |
| JO3555B1 (ar) | 2015-10-29 | 2020-07-05 | Merck Sharp & Dohme | جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري |
| CA3040893A1 (en) | 2016-10-21 | 2018-04-26 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| CN110035771B (zh) | 2016-10-21 | 2024-03-08 | 阿迪马布有限责任公司 | 抗呼吸道合胞病毒抗体及其产生和使用方法 |
| WO2018075954A2 (en) * | 2016-10-21 | 2018-04-26 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| TWI683826B (zh) * | 2016-11-22 | 2020-02-01 | 國立臺灣大學 | 重組ｒｓｖ抗原 |
| TW202228779A (zh) | 2017-03-01 | 2022-08-01 | 英商梅迪繆思有限公司 | 抗rsv單株抗體配製物 |
| US12024553B2 (en) | 2019-04-30 | 2024-07-02 | Medimmune Limited | Dosage regimens for and compositions including anti-RSV antibodies |
| CN111208307B (zh) * | 2020-04-21 | 2020-07-17 | 上海普铭生物科技有限公司 | 一种与参照分子具有相同或不同的靶蛋白结合的分子的筛选方法 |
| CN119462859A (zh) * | 2023-08-09 | 2025-02-18 | 深圳瑞吉生物科技有限公司 | 呼吸道合胞病毒抗原性多肽、疫苗及其应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020018780A1 (en) * | 2000-05-25 | 2002-02-14 | Scott Koenig | Epitope-based vaccine for respiratory syncytial virus F-protein |
| WO2012089231A1 (en) * | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| JP2011519828A (ja) * | 2008-04-18 | 2011-07-14 | バクシネート コーポレーション | フラジェリンの欠失変異体と使用方法 |
| WO2010107847A1 (en) | 2009-03-16 | 2010-09-23 | Sanofi Pasteur Biologics Co. | Replication-defective flavivirus vaccine vectors against respiratory syncytial virus |
| KR101789343B1 (ko) | 2009-10-06 | 2017-10-23 | 메드임뮨 리미티드 | Ｒｓｖ-특이적 결합 분자 |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| WO2011056899A2 (en) | 2009-11-03 | 2011-05-12 | Ligocyte Pharmaceuticals, Inc. | Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps |
| US9738689B2 (en) | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
| WO2014160463A1 (en) | 2013-03-13 | 2014-10-02 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Prefusion rsv f proteins and their use |
| US9060975B2 (en) | 2013-03-14 | 2015-06-23 | Mucosis Bv | Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions |
-
2014
- 2014-01-31 AU AU2014212268A patent/AU2014212268B2/en active Active
- 2014-01-31 DK DK14746750.0T patent/DK2950886T3/da active
- 2014-01-31 SI SI201431530T patent/SI2950886T1/sl unknown
- 2014-01-31 EP EP14746750.0A patent/EP2950886B1/en active Active
- 2014-01-31 CA CA2900110A patent/CA2900110A1/en not_active Abandoned
- 2014-01-31 JP JP2015556154A patent/JP6450688B2/ja active Active
- 2014-01-31 HR HRP20200404TT patent/HRP20200404T1/hr unknown
- 2014-01-31 WO PCT/US2014/014054 patent/WO2014121021A1/en not_active Ceased
- 2014-01-31 CN CN201480007046.4A patent/CN105073196B/zh active Active
- 2014-01-31 ES ES14746750T patent/ES2778899T3/es active Active
- 2014-01-31 SM SM20200145T patent/SMT202000145T1/it unknown
- 2014-01-31 PL PL14746750T patent/PL2950886T3/pl unknown
- 2014-01-31 LT LTEP14746750.0T patent/LT2950886T/lt unknown
- 2014-01-31 PT PT147467500T patent/PT2950886T/pt unknown
- 2014-01-31 US US14/764,635 patent/US10016496B2/en active Active
- 2014-01-31 RS RS20200305A patent/RS60056B1/sr unknown
-
2020
- 2020-03-18 CY CY20201100248T patent/CY1122937T1/el unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020018780A1 (en) * | 2000-05-25 | 2002-02-14 | Scott Koenig | Epitope-based vaccine for respiratory syncytial virus F-protein |
| WO2012089231A1 (en) * | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
Non-Patent Citations (1)
| Title |
|---|
| MCLELLAN et aL"Structural basis of respiratory syncytial virus neutralization by motavizumab," Nature Structural & Molecular Biology, 24 January 2010 (24.01.2010), Vol. 17, No. 2, pages 248-250 and Supplemental Materials. entire document * |
Also Published As
| Publication number | Publication date |
|---|---|
| CY1122937T1 (el) | 2020-10-14 |
| CA2900110A1 (en) | 2014-08-07 |
| US10016496B2 (en) | 2018-07-10 |
| PL2950886T3 (pl) | 2020-06-01 |
| EP2950886A1 (en) | 2015-12-09 |
| SI2950886T1 (sl) | 2020-06-30 |
| HRP20200404T1 (hr) | 2020-06-12 |
| EP2950886B1 (en) | 2019-12-18 |
| EP2950886A4 (en) | 2016-09-07 |
| CN105073196B (zh) | 2020-04-07 |
| LT2950886T (lt) | 2020-07-10 |
| AU2014212268A1 (en) | 2015-08-20 |
| WO2014121021A1 (en) | 2014-08-07 |
| SMT202000145T1 (it) | 2020-05-08 |
| CN105073196A (zh) | 2015-11-18 |
| JP6450688B2 (ja) | 2019-01-09 |
| RS60056B1 (sr) | 2020-04-30 |
| JP2016508503A (ja) | 2016-03-22 |
| ES2778899T3 (es) | 2020-08-12 |
| US20150366960A1 (en) | 2015-12-24 |
| PT2950886T (pt) | 2020-03-26 |
| DK2950886T3 (da) | 2020-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014212268B2 (en) | Respiratory Syncytial Virus F protein epitopes | |
| CN107847580B (zh) | 针对rsv的疫苗 | |
| US9060975B2 (en) | Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions | |
| TWI867291B (zh) | 經改良之冠狀病毒疫苗 | |
| US20210188949A1 (en) | Antibodies that potently neutralize rsv and uses thereof | |
| TW201522367A (zh) | 結合到ｒｓｖ ｇ蛋白之人類抗體 | |
| TW201534619A (zh) | 結合到ｒｓｖ ｇ蛋白之人類抗體 | |
| CN103476788A (zh) | 免疫原性屈曲病毒肽 | |
| US9499590B2 (en) | Antibodies against and methods for producing vaccines for respiratory syncytial virus | |
| JP2009022186A (ja) | 抗原ペプチドおよびその利用 | |
| KR20150135231A (ko) | 인간 메타뉴모바이러스에 특이적인 인간 항체 또는 그의 항원 결합성 단편 | |
| US20240409620A1 (en) | Design and application of fully human antibody for neutralizing respiratory syncytial virus | |
| CN114163504A (zh) | SARS-CoV-2 S蛋白RBD区中和表位肽及其应用 | |
| CN116847881A (zh) | 经改良的冠状病毒疫苗 | |
| US20220340658A1 (en) | NEUTRALIZING ANTI-SARS-CoV-2 ANTIBODIES AND USE THEREOF | |
| CN112574297A (zh) | 抗神经氨酸酶的单克隆抗体及其应用 | |
| CN105542003B (zh) | 一种针对rsv粘附g蛋白表面抗原的全人源单克隆抗体 | |
| EP3076999B1 (en) | Recombinant respiratory syncytial virus g protein fragments | |
| CN104628850B (zh) | Rsv-特异性结合分子 | |
| RU2816182C2 (ru) | Усовершенствованная коронавирусная вакцина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) |